| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |